Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARDELYX, INC. Director's Dealing 2016

Jan 21, 2016

32003_dirs_2016-01-20_c8da709b-b3ae-4800-983a-dce456b25837.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARDELYX, INC. (ARDX)
CIK: 0001437402
Period of Report: 2016-01-15

Reporting Person: Caldwell Jeremy S (EVP, Chief Scientific Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-01-15 Stock Option (Right to Buy) $10.55 A 164322 Acquired 2026-01-15 Common Stock (164322) Direct

Footnotes

F1: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 15, 2016, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.